#aagth ,,congress #ast ,session ,h4 ,r4 #baah ,,an ,,act ,to authorize ,united ,states participation in the ,coalition for ,epidemic ,preparedness ,innovations1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,securing ,america ,from ,epidemics ,act4 #b4 ,findings ,congress finds the following3 7#a7 ,due to increasing population and population density1 human mobility1 and ecological change1 emerging infectious diseases pose a real and growing threat to global health security4 7#b7 ,while vaccines can be the most effective tools to protect against infectious disease1 the absence of vaccines for a new or emerging infectious disease with epidemic potential is a major health security threat globally1 posing catastrophic potential human and economic costs4 7#c7 ,the ,,covid-#ai pandemic has infected more than #aai1ifj1gjj individuals and has killed at least #b1fef1hbb people worldwide1 and it is likely that unreported cases and deaths are significant4 7#d7 ,even regional outbreaks can have enormous human costs and substantially disrupt the global economy and cripple regional economies4 ,the #bjad ,ebola outbreak in ,west ,africa killed more than #aa1jjj and cost #b1hjj1jjj1jjj in losses in the affected countries alone4 7#e7 ,while the need for vaccines to address emerging epidemic threats is acute1 markets to drive the necessary development of vaccines to address them--a complex and expensive undertaking--are very often critically absent4 ,also absent are mechanisms to ensure access to those vaccines by those who need them when they need them4 7#f7 ,to address this global vulnerability and the deficit of political commitment1 institutional capacity1 and funding1 in #bjag1 several countries and private partners launched the ,coalition for ,epidemic ,preparedness ,innovations 7,,cepi74 ,,cepi's mission is to stimulate1 finance1 and coordinate development of vaccines for high-priority1 epidemic-potential threats in cases where traditional markets do not exist or cannot create sufficient demand4 7#g7 ,through funding of partnerships1 ,,cepi seeks to bring priority vaccines candidates through the end of phase ,,ii clinical trials1 as well as support vaccine platforms that can be rapidly deployed against emerging pathogens4 7#h7 ,,cepi supported the manufacturing of the ,united ,states-developed ,moderna ,,covid-#ai vaccine during its ,phase #a clinical trial1 and ,,cepi has initiated at least #ab partnerships to develop vaccines against ,,covid-#ai4 7#i7 ,,cepi is co-leading ,,covax1 the vaccines pillar of the ,,act-,accelerator1 which is a global collaboration to quickly produce and equitably distribute safe and effective vaccines and therapeutics for ,,covid-#ai4 7#aj7 ,support for and participation in ,,cepi is an important part of the ,united ,states own health security and biodefense and is in the national interest1 complementing the work of many ,federal agencies and providing significant value through global partnership and burden-sharing4 #c4 ,authorization for ,united ,states participation 7a7 ,in general ,the ,united ,states is hereby authorized to participate in the ,coalition for ,epidemic ,preparedness ,innovations 7,coalition74 7b7 ,designation ,the ,president is authorized to designate an employee of the relevant ,federal department or agency providing the majority of ,united ,states contributions to the ,coalition1 who should demonstrate knowledge and experience in the fields of development and public health1 epidemiology1 or medicine1 to serve-- 7#a7 on the ,investors ,council of the ,coalition2 and 7#b7 if nominated by the ,president1 on the ,board of ,directors of the ,coalition1 as a representative of the ,united ,states4 7c7 ,reports to ,congress ,not later than #ahj days after the date of the enactment of this ,act1 the ,president shall submit to the appropriate congressional committees a report that includes the following3 7#a7 ,the ,united ,states planned contributions to the ,coalition and the mechanisms for ,united ,states participation in such ,coalition4 7#b7 ,the manner and extent to which the ,united ,states shall participate in the governance of the ,coalition4 7#c7 ,how participation in the ,coalition supports relevant ,united ,states ,government strategies and programs in health security and biodefense1 including-- 7,a7 the ,global ,health ,security ,strategy required by section #gjeh7;c77#c7 of division ,k of the ,consolidated ,appropriations ,act1 #bjah 7,public ,law #aae-ada72 7,b7 the applicable revision of the ,national ,biodefense ,strategy required by section #ajhf of the ,national ,defense ,authorization ,act for ,fiscal ,year #bjag 7#f ,u4,s4,c4 #ajd72 and 7,c7 any other relevant decision-making process for policy1 planning1 and spending in global health security1 biodefense1 or vaccine and medical countermeasures research and development4 7d7 ,united ,states contributions ,amounts authorized to be appropriated under chapters #a and #aj of part ,i and chapter #d of part ,,ii of the ,foreign ,assistance ,act of #aifa 7#bb ,u4,s4,c4 #baea et seq47 are authorized to be made available for ,united ,states contributions to the ,coalition4 7e7 ,appropriate congressional committees ,in this section1 the term appropriate congressional committees means-- 7#a7 the ,committee on ,foreign ,affairs and the ,committee on ,appropriations of the ,house of ,representatives2 and 7#b7 the ,committee on ,foreign ,relations and the ,committee on ,appropriations of the ,senate4 ,passed the ,house of ,representatives ,july #bj1 #bjba4;,clerk4